BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng LE, Kanwar B, Tcheurekdjian H, Grenert JP, Muskat M, Heyman MB, McCune JM, Wara DW. Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome. Clin Immunol. 2009;132:124-131. [PMID: 19375390 DOI: 10.1016/j.clim.2009.03.514] [Cited by in Crossref: 62] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Ramírez-Alejo N, Alcántara-Montiel JC, Yamazaki-Nakashimada M, Duran-McKinster C, Valenzuela-León P, Rivas-Larrauri F, Cedillo-Barrón L, Hernández-Rivas R, Santos-Argumedo L. Novel hypomorphic mutation in IKBKG impairs NEMO-ubiquitylation causing ectodermal dysplasia, immunodeficiency, incontinentia pigmenti, and immune thrombocytopenic purpura. Clin Immunol 2015;160:163-71. [PMID: 26117626 DOI: 10.1016/j.clim.2015.06.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
2 Surucu Yilmaz N, Bilgic Eltan S, Kayaoglu B, Geckin B, Heredia RJ, Sefer AP, Kiykim A, Nain E, Kasap N, Dogru O, Yucelten AD, Cinel L, Karasu G, Yesilipek A, Sozeri B, Kaya GG, Yilmaz IC, Baydemir I, Aydin Y, Cansen Kahraman D, Haimel M, Boztug K, Karakoc-Aydiner E, Gursel I, Ozen A, Baris S, Gursel M. Low Density Granulocytes and Dysregulated Neutrophils Driving Autoinflammatory Manifestations in NEMO Deficiency. J Clin Immunol 2022. [PMID: 35028801 DOI: 10.1007/s10875-021-01176-3] [Reference Citation Analysis]
3 Louis E. When it is not inflammatory bowel disease: differential diagnosis. Curr Opin Gastroenterol 2015;31:283-9. [PMID: 26039719 DOI: 10.1097/MOG.0000000000000183] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Engelhardt KR, Grimbacher B. IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms. Curr Top Microbiol Immunol. 2014;380:1-18. [PMID: 25004811 DOI: 10.1007/978-3-662-43492-5_1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 56] [Article Influence: 3.4] [Reference Citation Analysis]
5 Heller S, Kölsch U, Magg T, Krüger R, Scheuern A, Schneider H, Eichinger A, Wahn V, Unterwalder N, Lorenz M, Schwarz K, Meisel C, Schulz A, Hauck F, von Bernuth H. T Cell Impairment Is Predictive for a Severe Clinical Course in NEMO Deficiency. J Clin Immunol 2020;40:421-34. [DOI: 10.1007/s10875-019-00728-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Mizukami T, Obara M, Nishikomori R, Kawai T, Tahara Y, Sameshima N, Marutsuka K, Nakase H, Kimura N, Heike T, Nunoi H. Successful treatment with infliximab for inflammatory colitis in a patient with X-linked anhidrotic ectodermal dysplasia with immunodeficiency. J Clin Immunol. 2012;32:39-49. [PMID: 21993693 DOI: 10.1007/s10875-011-9600-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
7 Frede N, Glocker EO, Wanders J, Engelhardt KR, Kreisel W, Ruemmele FM, Grimbacher B. Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel disease. BMC Immunol 2014;15:10. [PMID: 24581234 DOI: 10.1186/1471-2172-15-10] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
8 Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, Keller M, Kobrynski LJ, Komarow HD, Mazer B. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015;136:1186-1205.e1-78. [PMID: 26371839 DOI: 10.1016/j.jaci.2015.04.049] [Cited by in Crossref: 292] [Cited by in F6Publishing: 242] [Article Influence: 41.7] [Reference Citation Analysis]
9 Zilberman-Rudenko J, Shawver LM, Wessel AW, Luo Y, Pelletier M, Tsai WL, Lee Y, Vonortas S, Cheng L, Ashwell JD, Orange JS, Siegel RM, Hanson EP. Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory disease. Proc Natl Acad Sci U S A 2016;113:1612-7. [PMID: 26802121 DOI: 10.1073/pnas.1518163113] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
10 Both T, Dalm VASH, Richardson SA, van Schie N, van den Broek LM, de Vries AC, van Hagen PM, Rombach SM. Inflammatory bowel disease in primary immunodeficiency disorders is a heterogeneous clinical entity requiring an individualized treatment strategy: A systematic review. Autoimmun Rev 2021;20:102872. [PMID: 34118459 DOI: 10.1016/j.autrev.2021.102872] [Reference Citation Analysis]
11 Schwerd T, Bryant RV, Pandey S, Capitani M, Meran L, Cazier JB, Jung J, Mondal K, Parkes M, Mathew CG, Fiedler K, McCarthy DJ, Sullivan PB, Rodrigues A, Travis SPL, Moore C, Sambrook J, Ouwehand WH, Roberts DJ, Danesh J, Russell RK, Wilson DC, Kelsen JR, Cornall R, Denson LA, Kugathasan S, Knaus UG, Serra EG, Anderson CA, Duerr RH, McGovern DP, Cho J, Powrie F, Li VS, Muise AM, Uhlig HH; WGS500 Consortium., Oxford IBD cohort study investigators., COLORS in IBD group investigators., UK IBD Genetics Consortium., INTERVAL Study. NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease. Mucosal Immunol 2018;11:562-74. [PMID: 29091079 DOI: 10.1038/mi.2017.74] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 8.6] [Reference Citation Analysis]
12 Klemann C, Pannicke U, Morris-Rosendahl DJ, Vlantis K, Rizzi M, Uhlig H, Vraetz T, Speckmann C, Strahm B, Pasparakis M, Schwarz K, Ehl S, Rohr JC. Transplantation from a symptomatic carrier sister restores host defenses but does not prevent colitis in NEMO deficiency. Clin Immunol 2016;164:52-6. [PMID: 26812624 DOI: 10.1016/j.clim.2016.01.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
13 Piccoli GB, Attini R, Vigotti FN, Naretto C, Fassio F, Randone O, Restagno G, Todros T, Roccatello D. NEMO syndrome (incontinentia pigmenti) and systemic lupus erythematosus: a new disease association. Lupus 2012;21:675-81. [PMID: 22235006 DOI: 10.1177/0961203311433140] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
14 Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A, Ouahed J, Wilson DC, Travis SP, Turner D. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147:990-1007.e3. [PMID: 25058236 DOI: 10.1053/j.gastro.2014.07.023] [Cited by in Crossref: 345] [Cited by in F6Publishing: 294] [Article Influence: 43.1] [Reference Citation Analysis]
15 Yang Y, Guo Y, Ping Y, Zhou XG, Li Y. Neonatal incontinentia pigmenti: Six cases and a literature review. Exp Ther Med 2014;8:1797-806. [PMID: 25371735 DOI: 10.3892/etm.2014.2011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
16 Kohn LL, Braun M, Cordoro KM, McCalmont TH, Shah SD, Frieden IJ, Mathur AN. Skin and Mucosal Manifestations in NEMO Syndrome: A Case Series and Literature Review. Pediatr Dermatol 2022. [PMID: 34989033 DOI: 10.1111/pde.14905] [Reference Citation Analysis]
17 Schimke LF, Rieber N, Rylaarsdam S, Cabral-marques O, Hubbard N, Puel A, Kallmann L, Sombke SA, Notheis G, Schwarz H, Kammer B, Hökfelt T, Repp R, Picard C, Casanova J, Belohradsky BH, Albert MH, Ochs HD, Renner ED, Torgerson TR. A Novel Gain-of-Function IKBA Mutation Underlies Ectodermal Dysplasia with Immunodeficiency and Polyendocrinopathy. J Clin Immunol 2013;33:1088-99. [DOI: 10.1007/s10875-013-9906-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
18 Faletra F, Bruno I, Berti I, Pastore S, Pirrone A, Tommasini A. A red baby should not be taken too lightly. Acta Paediatr. 2012;101:e573-e577. [PMID: 22946961 DOI: 10.1111/apa.12018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
19 Eames HL, Corbin AL, Udalova IA. Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease. Transl Res 2016;167:167-82. [PMID: 26207886 DOI: 10.1016/j.trsl.2015.06.018] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
20 Lee WI, Chen CC, Jaing TH, Ou LS, Hsueh C, Huang JL. A Nationwide Study of Severe and Protracted Diarrhoea in Patients with Primary Immunodeficiency Diseases. Sci Rep 2017;7:3669. [PMID: 28623282 DOI: 10.1038/s41598-017-03967-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Hartono S, Ippoliti MR, Mastroianni M, Torres R, Rider NL. Gastrointestinal Disorders Associated with Primary Immunodeficiency Diseases. Clin Rev Allergy Immunol 2019;57:145-65. [PMID: 29754192 DOI: 10.1007/s12016-018-8689-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
22 Shim JO. Recent advance in very early-onset inflammatory bowel disease. Intest Res 2019;17:9-16. [PMID: 30419637 DOI: 10.5217/ir.2018.00130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
23 Gong J, Xu J, Zhu W, Gao X, Li N, Li J. Epithelial-specific blockade of MyD88-dependent pathway causes spontaneous small intestinal inflammation. Clin Immunol 2010;136:245-56. [PMID: 20452828 DOI: 10.1016/j.clim.2010.04.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 3.7] [Reference Citation Analysis]
24 Gecse KB, Vermeire S. Differential diagnosis of inflammatory bowel disease: imitations and complications. Lancet Gastroenterol Hepatol 2018;3:644-53. [PMID: 30102183 DOI: 10.1016/S2468-1253(18)30159-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
25 Kaustio M, Haapaniemi E, Göös H, Hautala T, Park G, Syrjänen J, Einarsdottir E, Sahu B, Kilpinen S, Rounioja S, Fogarty CL, Glumoff V, Kulmala P, Katayama S, Tamene F, Trotta L, Morgunova E, Krjutškov K, Nurmi K, Eklund K, Lagerstedt A, Helminen M, Martelius T, Mustjoki S, Taipale J, Saarela J, Kere J, Varjosalo M, Seppänen M. Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes. J Allergy Clin Immunol 2017;140:782-96. [PMID: 28115215 DOI: 10.1016/j.jaci.2016.10.054] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 11.6] [Reference Citation Analysis]
26 Kelsen JR, Baldassano RN, Artis D, Sonnenberg GF. Maintaining intestinal health: the genetics and immunology of very early onset inflammatory bowel disease. Cell Mol Gastroenterol Hepatol 2015;1:462-76. [PMID: 26393237 DOI: 10.1016/j.jcmgh.2015.06.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
27 Huppmann AR, Leiding JW, Hsu AP, Raffeld M, Uzel G, Pittaluga S, Holland SM. Pathologic Findings in NEMO Deficiency: A Surgical and Autopsy Survey. Pediatr Dev Pathol 2015;18:387-400. [PMID: 26230867 DOI: 10.2350/15-05-1631-OA.1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
28 Sun X, Huang Y, Si D, Gao S, Wang P. Questionnaire survey on association between preeclampsia and incontinentia pigmenti. J Obstet Gynaecol Res 2019;45:1363-70. [PMID: 31106959 DOI: 10.1111/jog.13983] [Reference Citation Analysis]
29 Ouahed J, Spencer E, Kotlarz D, Shouval DS, Kowalik M, Peng K, Field M, Grushkin-Lerner L, Pai SY, Bousvaros A, Cho J, Argmann C, Schadt E, Mcgovern DPB, Mokry M, Nieuwenhuis E, Clevers H, Powrie F, Uhlig H, Klein C, Muise A, Dubinsky M, Snapper SB. Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies. Inflamm Bowel Dis 2020;26:820-42. [PMID: 31833544 DOI: 10.1093/ibd/izz259] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 20.0] [Reference Citation Analysis]
30 Nazi N, Ladomenou F. Gastrointestinal manifestations of primary immune deficiencies in children. Int Rev Immunol 2018;37:111-8. [PMID: 28876962 DOI: 10.1080/08830185.2017.1365147] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
31 Shah N, Kammermeier J, Elawad M, Glocker EO. Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel disease. Curr Allergy Asthma Rep. 2012;12:373-379. [PMID: 22890722 DOI: 10.1007/s11882-012-0286-z] [Cited by in Crossref: 71] [Cited by in F6Publishing: 58] [Article Influence: 7.9] [Reference Citation Analysis]
32 Lee WI, Huang JL, Chen CC, Lin JL, Wu RC, Jaing TH, Ou LS. Identifying Mutations of the Tetratricopeptide Repeat Domain 37 (TTC37) Gene in Infants With Intractable Diarrhea and a Comparison of Asian and Non-Asian Phenotype and Genotype: A Global Case-report Study of a Well-Defined Syndrome With Immunodeficiency. Medicine (Baltimore) 2016;95:e2918. [PMID: 26945392 DOI: 10.1097/MD.0000000000002918] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
33 de Jesus AA, Canna SW, Liu Y, Goldbach-Mansky R. Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annu Rev Immunol 2015;33:823-74. [PMID: 25706096 DOI: 10.1146/annurev-immunol-032414-112227] [Cited by in Crossref: 173] [Cited by in F6Publishing: 137] [Article Influence: 24.7] [Reference Citation Analysis]
34 Bianco AM, Girardelli M, Tommasini A. Genetics of inflammatory bowel disease from multifactorial to monogenic forms. World J Gastroenterol 2015; 21(43): 12296-12310 [PMID: 26604638 DOI: 10.3748/wjg.v21.i43.12296] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
35 Engelhardt KR, Shah N, Faizura-Yeop I, Kocacik Uygun DF, Frede N, Muise AM, Shteyer E, Filiz S, Chee R, Elawad M. Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2013;131:825-830. [PMID: 23158016 DOI: 10.1016/j.jaci.2012.09.025] [Cited by in Crossref: 178] [Cited by in F6Publishing: 152] [Article Influence: 17.8] [Reference Citation Analysis]
36 Akar-Ghibril N. Defects of the Innate Immune System and Related Immune Deficiencies. Clin Rev Allergy Immunol 2021. [PMID: 34417936 DOI: 10.1007/s12016-021-08885-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Shim JO. Recent Advance in Very Early Onset Inflammatory Bowel Disease. Pediatr Gastroenterol Hepatol Nutr 2019;22:41-9. [PMID: 30671372 DOI: 10.5223/pghn.2019.22.1.41] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
38 Ma CA, Wang HY, Temmerman S, Zhao Y, Wu L, Hornung RL, Wara D, Jain A. Dendritic cells from humans with hypomorphic mutations in IKBKG/NEMO have impaired mitogen-activated protein kinase activity. Hum Mutat 2011;32:318-24. [PMID: 21309033 DOI: 10.1002/humu.21439] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
39 Lipinski S, Petersen BS, Barann M, Piecyk A, Tran F, Mayr G, Jentzsch M, Aden K, Stengel ST, Klostermeier UC, Sheth V, Ellinghaus D, Rausch T, Korbel JO, Nothnagel M, Krawczak M, Gilissen C, Veltman JA, Forster M, Forster P, Lee CC, Fritscher-Ravens A, Schreiber S, Franke A, Rosenstiel P. Missense variants in NOX1 and p22phox in a case of very-early-onset inflammatory bowel disease are functionally linked to NOD2. Cold Spring Harb Mol Case Stud 2019;5:a002428. [PMID: 30709874 DOI: 10.1101/mcs.a002428] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
40 Batura V, Muise AM. Very early onset IBD: novel genetic aetiologies. Curr Opin Allergy Clin Immunol 2018;18:470-80. [PMID: 30299396 DOI: 10.1097/ACI.0000000000000486] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
41 Leung G, Muise AM. Monogenic Intestinal Epithelium Defects and the Development of Inflammatory Bowel Disease. Physiology (Bethesda) 2018;33:360-9. [PMID: 30109822 DOI: 10.1152/physiol.00020.2018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
42 Uhlig HH. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease. Gut. 2013;62:1795-1805. [PMID: 24203055 DOI: 10.1136/gutjnl-2012-303956] [Cited by in Crossref: 216] [Cited by in F6Publishing: 193] [Article Influence: 27.0] [Reference Citation Analysis]
43 Fodil N, Langlais D, Gros P. Primary Immunodeficiencies and Inflammatory Disease: A Growing Genetic Intersection. Trends Immunol 2016;37:126-40. [PMID: 26791050 DOI: 10.1016/j.it.2015.12.006] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
44 Murugan D, Albert MH, Langemeier J, Bohne J, Puchalka J, Järvinen PM, Hauck F, Klenk AK, Prell C, Schatz S, Diestelhorst J, Sciskala B, Kohistani N, Belohradsky BH, Müller S, Kirchner T, Walter MR, Bufler P, Muise AM, Snapper SB, Koletzko S, Klein C, Kotlarz D. Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantation. J Clin Immunol 2014;34:331-9. [PMID: 24519095 DOI: 10.1007/s10875-014-9992-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 5.8] [Reference Citation Analysis]
45 Lien R, Lin YF, Lai MW, Weng HY, Wu RC, Jaing TH, Huang JL, Tsai SF, Lee WI. Novel Mutations of the Tetratricopeptide Repeat Domain 7A Gene and Phenotype/Genotype Comparison. Front Immunol 2017;8:1066. [PMID: 28936210 DOI: 10.3389/fimmu.2017.01066] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
46 Martuszewski A, Paluszkiewicz P, Sierżęga-Staykov K, Wawrzyniak-Dzierżek E, Salamonowicz-Bodzioch M, Frączkiewicz J, Janeczko-Czarnecka M, Mielcarek-Siedziuk M, Nowak M, Dąbrowska-Leonik N, Wolska-Kuśnierz B, Gul K, Bąbol-Pokora K, Młynarski W, Kałwak K, Ussowicz M. Successful Allogeneic Stem Cell Transplantation in Nuclear Factor-Kappa B Essential Modulator Deficiency Syndrome After Treosulfan-Based Conditioning: A Case Report. Transplant Proc 2020;52:647-52. [PMID: 32035679 DOI: 10.1016/j.transproceed.2019.11.033] [Reference Citation Analysis]